Literature DB >> 19741715

Genetic association of htSNPs across the major histocompatibility complex with rheumatoid arthritis in an African-American population.

R J Reynolds1, J M Kelley, L B Hughes, N Yi, S L Bridges.   

Abstract

Notwithstanding the well-established association of HLA-DRB1 shared epitope alleles, interest remains in identifying additional major histocompatibility complex (MHC) region variants associated with rheumatoid arthritis (RA). We used a panel of 1201 haplotype-tagging single nucleotide polymorphisms (SNPs) designed for African Americans to find genetic variants associated with RA in a 3.8-Mb region encompassing the MHC. Conditioning on seven covariates, including HLA-DRB1 risk alleles and population structure, we identified an SNP in HLA-DOA (rs9276977) significantly associated with RA; minor allele frequency (MAF) 0.27 in cases versus 0.21 in controls, odds ratio (+/-95% confidence interval)=2.86 (1.61, 5.31). Genotyping of rs9276977 in an independent sample of African-American RA patients and controls did not replicate the association (MAF 0.28 in cases versus 0.27 in controls). This study points to the potential association of a SNP in the HLA-DOA gene with RA in African Americans, but also underscores the importance of replication of findings in larger patient cohorts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741715      PMCID: PMC2809137          DOI: 10.1038/gene.2009.69

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  10 in total

1.  Novel polymorphisms in HLA-DOA and HLA-DOB in B-cell malignancies.

Authors:  Marcel van Lith; Marieke van Ham; Jacques Neefjes
Journal:  Immunogenetics       Date:  2002-10-09       Impact factor: 2.846

2.  Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis.

Authors:  Ted R Mikuls; V Michael Holers; Lezlie Parrish; Kristine A Kuhn; Doyt L Conn; Gary Gilkeson; Edwin A Smith; Diane L Kamen; Beth L Jonas; Leigh F Callahan; Graciela S Alarcón; George Howard; Larry W Moreland; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2006-09

Review 3.  Right place, right time, right peptide: DO keeps DM focused.

Authors:  Lisa K Denzin; Jennifer L Fallas; Maria Prendes; Woelsung Yi
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

4.  Evaluating linkage disequilibrium and recombination provides a haplotype-tagging SNP panel of the major histocompatibility complex in African Americans.

Authors:  J M Kelley; L B Hughes; R Feng; N Liu; M A Padilla; L K Vaughan; S L Bridges
Journal:  Genes Immun       Date:  2008-02-28       Impact factor: 2.676

5.  A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms.

Authors:  Xiaoyi Gao; Joshua Starmer; Eden R Martin
Journal:  Genet Epidemiol       Date:  2008-05       Impact factor: 2.135

Review 6.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

Authors:  P K Gregersen; J Silver; R J Winchester
Journal:  Arthritis Rheum       Date:  1987-11

7.  Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.

Authors:  Bo Ding; Leonid Padyukov; Emeli Lundström; Mark Seielstad; Robert M Plenge; Jorge R Oksenberg; Peter K Gregersen; Lars Alfredsson; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2009-01

8.  Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci.

Authors:  Charlotte Vignal; Aruna T Bansal; David J Balding; Michael H Binks; Marion C Dickson; Doug S Montgomery; Anthony G Wilson
Journal:  Arthritis Rheum       Date:  2009-01

9.  The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture.

Authors:  Laura B Hughes; Dahliann Morrison; James M Kelley; Miguel A Padilla; L Kelly Vaughan; Andrew O Westfall; Harshit Dwivedi; Ted R Mikuls; V Michael Holers; Lezlie A Parrish; Graciela S Alarcón; Doyt L Conn; Beth L Jonas; Leigh F Callahan; Edwin A Smith; Gary S Gilkeson; George Howard; Larry W Moreland; Nick Patterson; David Reich; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2008-02

Review 10.  A tutorial on statistical methods for population association studies.

Authors:  David J Balding
Journal:  Nat Rev Genet       Date:  2006-10       Impact factor: 53.242

  10 in total
  7 in total

Review 1.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

2.  RNA-sequencing study of peripheral blood monocytes in chronic periodontitis.

Authors:  Yao-Zhong Liu; Pooja Maney; Jyoti Puri; Yu Zhou; Melody Baddoo; Michael Strong; Yu-Ping Wang; Erik Flemington; Hong-Wen Deng
Journal:  Gene       Date:  2016-01-23       Impact factor: 3.688

3.  Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma.

Authors:  Berran Yucesoy; Victor J Johnson; Zana L Lummus; Michael L Kashon; Marepalli Rao; Hansen Bannerman-Thompson; Bonnie Frye; Wei Wang; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Dori R Germolec; Michael I Luster; David I Bernstein
Journal:  J Occup Environ Med       Date:  2014-04       Impact factor: 2.162

Review 4.  The love and hate relationship of HLA-DM/DO in the selection of immunodominant epitopes.

Authors:  Robin A Welsh; Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2020-06-28       Impact factor: 7.486

Review 5.  HLA-DO and Its Role in MHC Class II Antigen Presentation.

Authors:  Yuri O Poluektov; Aeryon Kim; Scheherazade Sadegh-Nasseri
Journal:  Front Immunol       Date:  2013-08-29       Impact factor: 7.561

6.  HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.

Authors:  Yuri O Poluektov; Aeryon Kim; Isamu Z Hartman; Scheherazade Sadegh-Nasseri
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

7.  Lack of the MHC class II chaperone H2-O causes susceptibility to autoimmune diseases.

Authors:  Robin A Welsh; Nianbin Song; Catherine A Foss; Tatiana Boronina; Robert N Cole; Scheherazade Sadegh-Nasseri
Journal:  PLoS Biol       Date:  2020-02-18       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.